Korean Journal of Head & Neck Oncology (대한두경부종양학회지)

The Korean Society for Head and Neck Oncology (대한두경부종양학회)
권호 표지

Radiation Therapy in The Treatment of $T_1$ Glottic Cancer

병기 $T_1$ 성대종양 환자의 방사선치료성적에 관한 고찰

  • Lee Y.G. (Department of Radiation Oncology, Yonsei University College of Medicine, Yonsei Cancer Center) ;
  • Loh J.K. (Department of Radiation Oncology, Yonsei University College of Medicine, Yonsei Cancer Center) ;
  • Lee C.G. (Department of Radiation Oncology, Yonsei University College of Medicine, Yonsei Cancer Center) ;
  • Lee J.Y. (Department of Radiation Oncology, Yonsei University College of Medicine, Yonsei Cancer Center) ;
  • Kim G.E. (Department of Radiation Oncology, Yonsei University College of Medicine, Yonsei Cancer Center) ;
  • Suh C.O. (Department of Radiation Oncology, Yonsei University College of Medicine, Yonsei Cancer Center) ;
  • Houng W.P. (Department of Otolaryngoloy, Yonsei University College of Medicine, Yonsei Cancer Center)
  • 이연구 (연세대학교 의과대학 치료방사선과학교실) ;
  • 노준규 (연세대학교 의과대학 치료방사선과학교실) ;
  • 이창걸 (연세대학교 의과대학 치료방사선과학교실) ;
  • 이종영 (연세대학교 의과대학 치료방사선과학교실) ;
  • 김귀언 (연세대학교 의과대학 치료방사선과학교실) ;
  • 서창옥 (연세대학교 의과대학 치료방사선과학교실) ;
  • 홍원표 (연세대학교 의과대학 이비인후과학교실)
  • Published : 1988.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Radiation therapy is generally considered to be the treatment of choice in $T_1$ glottic cancer, maninly because of preservation of voice function and its local control rate is comparable to that of surgery. Failures from radiation therapy can be ultimately salvaged by surgery. A retrospective analysis of the treatment of 25 patients with $T_1$ glottic cancer seen at the Yonsei Cancer Center from 1980 to 1984 is presented. Radiation dose to the target volume varied from 6400 to 7000 cGy in 6-7 weeks. The local control rate is 84%. Four patients had primary failure and three of these patients had salvage surgery. Of the 3 patients who had salvage surgery, 2 were cured and aonther one was died with progression of the disease. 5-year acturial and disease free survival rate are 91.1%,78.0% respectively.

Keywords